Immunization Schedule For Children And Adolescents Aged 18 Years Or Younger Page 2

ADVERTISEMENT

Figure 1. Recommended immunization schedule for children and adolescents aged 18 years or
younger—United States, 2017.
(FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]).
These recommendations must be read with the footnotes that follow. For those who fall behind or start late, provide catch-up vaccination at the earliest opportunity as indicated by the green bars in Figure 1.
To determine minimum intervals between doses, see the catch-up schedule (Figure 2). School entry and adolescent vaccine age groups are shaded in gray.
19-23
Vaccine
Birth
1 mo
2 mos
4 mos
6 mos
9 mos
12 mos
15 mos
18 mos
2-3 yrs
4-6 yrs
7-10 yrs
11-12 yrs
13-15 yrs
16 yrs
17-18 yrs
mos
1
st
dose
2
nd
dose
3
rd
dose
Hepatitis B
1
(HepB)
Rotavirus
(RV) RV1 (2-dose
2
See
1
st
dose
2
nd
dose
series); RV5 (3-dose series)
footnote 2
Diphtheria, tetanus, & acellular
1
st
dose
2
nd
dose
3
rd
dose
4
th
dose
5
th
dose
pertussis
3
(DTaP: <7 yrs)
Haemophilus influenzae type b
4
See
3
or 4
dose,
rd
th
1
st
dose
2
nd
dose
footnote 4
See footnote 4
(Hib)
Pneumococcal conjugate
5
1
dose
2
dose
3
dose
4
dose
st
nd
rd
th
(PCV13)
Inactivated poliovirus
6
1
dose
2
dose
3
dose
4
dose
st
nd
rd
th
(IPV: <18 yrs)
Annual vaccination (IIV)
Influenza
7
(IIV)
Annual vaccination (IIV) 1 or 2 doses
1 dose only
Measles, mumps, rubella
8
(MMR)
See footnote 8
1
dose
2
nd
dose
st
Varicella
(VAR)
1
st
dose
2
nd
dose
9
Hepatitis A
1 0
(HepA)
2-dose series, See footnote 10
1 1
Meningococcal
(Hib-MenCY
>6 weeks; MenACWY-D >9 mos;
See footnote 11
1
dose
2
dose
st
nd
MenACWY-CRM ≥2 mos)
Tetanus, diphtheria, & acellular
Tdap
pertussis
1 2
(Tdap: >7 yrs)
See footnote
Human papillomavirus
(HPV)
1 3
13
See footnote 11
1 1
Meningococcal B
Pneumococcal polysaccharide
5
See footnote 5
(PPSV23)
Range of recommended
Range of recommended ages
Range of recommended ages
Range of recommended ages for non-high-risk
No recommendation
ages for all children
for catch-up immunization
for certain high-risk groups
groups that may receive vaccine, subject to
individual clinical decision making
NOTE: The above recommendations must be read along with the footnotes of this schedule.

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go
Page of 8